ChEBI Mrv0541 04191212142 d 22 25 0 0 1 0 999 V2000型16.9197 -13.7280 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 16.9196 -15.5818 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 17.7239 -15.3982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 17.7240 -13.9116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 16.2746 -14.2424 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 16.2746 -15.0674 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 15.5602 -14.6549 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 16.7692 -14.6346 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 17.4713 -14.6346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 018.0819 -14.6549 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 18.9069 -14.6549 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 19.6214 -15.8924 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 19.6214 -15.0674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 20.3358 -13.8299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 21.0503 -13.4174 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 20.3358 -14.6549 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 21.0503 -15.0674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 21.7648 -14.6549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 21.0503 -15.8924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 21.7648 -16.3049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 22.4792 -15.8924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 22.4792 -15.0674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 5 1 0 0 0 0 4 1 1 0 0 0 0 5 6 1 0 0 0 0 6 2 1 0 0 0 0 2 3 1 0 0 0 0 3 10 1 0 0 0 0 10 4 1 0 0 0 0 5 7 1 1 0 0 0 6 7 1 1 0 0 0 1 8 1 1 0 0 0 2 8 1 1 0 0 0 8 9 1 0 0 0 0 10 11 1 6 0 0 0 11 13 1 0 0 0 0 13 12 2 0 0 0 0 13 16 1 0 0 0 0 16 14 1 6 0 0 0 14 15 1 0 0 0 0 16 17 1 0 0 0 0 18 17 2 0 0 0 0 17 19 1 0 0 0 0 18 22 1 0 0 0 0 19 20 2 0 0 0 0 20 21 1 0 0 0 0 21 22 2 0 0 0 0 M END >
DB00747 >
drugbank >
CN1 [C@H] 2 C [C@@H] (C [C@@H] 1 [C@H] 1 O [C@@H] 21) OC (= O) [C@H] (CO) C1 = CC = CC = C1 >
InChI = 1 s / C17H21NO4 / c1-18-13-7-11 (8 - 14 (18) 16-15 (13) 22-16) 21 - 12 (9-19) (20) 10-5-3-2-4-6-10 / h2-6、16、19 h, 7-9H2, 1 h3 / t11 - 12、13、14 + 15 - 16 + / m1 / s1 >
STECJAGHUSJQJN-FWXGHANASA-N >
C17H21NO4 >
303.3529 >
303.147058165 >
4 >
43 >
0.47327165179743913 >
31.196802239045496 >
1 >
1 >
0 >
1 >
(1R,2R,4S,5S,7S)-9-甲基-3-氧-9-氮杂环[3.3.1.0^{2,4}]壬胺-7-基(2S)-3-羟基-2-苯丙酸>
1.40 >
0.8949522950000002 >
-1.66 >
0 >
1 >
4 >
0 >
15.145739865848089 >
6.953523808607151 >
62.3 >
79.72130000000003 >
5 >
1 >
6.61e+00 g/l >
四氢叶酸
0 >
DB00747 >
APRD00616 >
批准;临床实验的>
莨菪碱>
(-)东莨菪碱;(-)莨菪碱;(1 s, 3、5 r, 6 r, 7 s) 6, 7-Epoxytropan-3-yl (2 s) 3-hydroxy-2-phenylpropanoate;6-beta 7-beta-Epoxy-3-alpha-tropanyl S - (-) -tropate;6, 7-Epoxytropine tropate;-(羟甲基)苯乙酸9-甲基-3-氧-9-氮杂环(3.3.1.0(2.4))非7-基酯;东莨菪碱;-tropate scopine (-);scopine(−)-tropate;莨菪碱; Scopolamine hydrobromide >
阿替洛尔莨菪碱;B-Donna;颠茄生物碱与苯巴比妥;颠茄生物碱与苯巴比妥;智利帽;Donnagel液体;Donnatal;Donnatal长生不老药;Donnatal Extentabs;母婴扩展; Donnatal Tab; Isopto Hyoscine; Kimite; Me-PB-Hyos; PB Hyos; Phenobarbital With Belladonna Alkaloids; Phenobarbital with Belladonna Alkaloids; Phenobarbital with Belladonna Alkaloids - Grape; Phenobarbital with Belladonna Alkaloids - Mint; Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate and Scopolamine Hydrobromide; Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide; Phenohytro; Propranolol Scopolamine; Quadrapax; Re-PB Hyos; Re-PB Hyos Elixir; Scopace; Scopolamine; Scopolamine Bromide Trihydrate; Scopolamine Hydrobromide; Scopolamine Hydrobromide Injection; Scopolamine Hydrobromide Injection USP; Scopolamine Trandermal System; Se-donna Pb Hyos; Servira; Transderm Scop; Vitetal >
Scopoderm;Transderm-Scop $ $ $ $